Clinical Trials List
Protocol Number1434-0027
Not yet recruiting
2026-02-01 - 2028-05-31
Phase II
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 徐佳鈿 無
- TUNG-MIN YU 無
- CHENG-HSU CHEN 無
- 蔡尚峰 無
Co-Principal Investigator
- CHUN-FU LAI 無
- 楊紹佑 無
- 謝易庭 無
- WEN-CHIH CHIANG 無
- 黃道民 無
Co-Principal Investigator
- Chia-Te Liao 無
- 賴史忠 無
- YUNG-HO HSU 無
- 林冠宏 無
- Cai-Mei Zheng 無
- 高芷華 無
- Li-Yee Hong 無
- Yu-Wei Chen 無
- Mei-Yi Wu 無
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
132 participants
